HOME My AAPS
 
Large Text | Regular Text     
Log In.     
  Pharmaceutical Profiling in Drug Discovery for Lead Selection
  

Pharmaceutical Profiling in Drug Discovery for Lead Selection

Edited by: Ronald T. Borchardt, University of Kansas
Edward H. Kerns, Wyeth Research
Christopher A. Lipinski, Pfizer Global R & D (retired)
Dhiren R. Thakker, University of North Carolina
Binghe Wang, Georgia State University

Volume 1 of the upcoming AAPS Press series, Biotechnology: Pharmaceutical Aspects. Based on a 2003 AAPS workshop of the same name, Pharmaceutical Profiling in Drug Discovery for Lead Selection emphasizes the importance of accuracy in the prediction, measurement, and application of physiochemical and ADME properties, not only to guarantee successful lead selection in "hit-to-lead" research but also to avoid the common pitfalls that arise when property information is lacking. Its contributors include highly experienced leaders from both industry and academia, with specialization in advanced methods for in silico, physiochemical, permeability, in vitro, and ADME, as well as in medicinal chemistry applications on pharmaceutical property information. This book is the first volume of the Biotechnology - Pharmaceutical Aspects series.

List Price: $185.00; AAPS Member price: $138.75       Printable Order Form


Supporting Information and Data

Table of Contents
Question and Answer/Panel Discussion Transcripts
 
American Association of Pharmaceutical Scientists
2107 Wilson Blvd, Suite 700, Arlington, VA 22201-3042
Main Telephone: 703 243 2800 Main Fax: 703 243 9650
Email: AAPS
View disclaimer
View Privacy Statement
Please email your comments or questions regarding this web site to
Webmaster